TVGN – tevogen bio holdings inc. (US:NASDAQ)

News

Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical [Yahoo! Finance]
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
Tevogen Bio (TVGN) was downgraded by D. Boral Capital from "buy" to "hold".
Tevogen Announces Reverse Stock Split
Tevogen Bio (TVGN) had its price target lowered by D. Boral Capital from $5.00 to $2.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com